Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07575243
Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) ProtocolAssiut UniversityCompleted
NCT07575243Completed
—
Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) ProtocolAssiut University
NCT07574918
Measuring Nasal Airway Changes After VivAer Treatment Using AI Analysis.Aerin MedicalNot Yet RecruitingNot Applicable
NCT07574918Not Yet Recruiting
Not Applicable
Measuring Nasal Airway Changes After VivAer Treatment Using AI Analysis.Aerin Medical
NCT07574827
Candida Albicans in Syrian Patients With PeriodontitisAl-Hawash Private UniversityRecruiting
NCT07574827Recruiting
—
Candida Albicans in Syrian Patients With PeriodontitisAl-Hawash Private Univers...
NCT07575438
Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk AdultsDiabetes CanadaNot Yet RecruitingPhase 2
NCT07575438Not Yet Recruiting
Phase 2
Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk...Diabetes Canada
NCT07574710
Effects of Implant Placement Depth (4 mm Versus 6 mm) on Crestal Bone Stability in Immediate Implant Placement: A Clinical Study With 1-Year Post-Restorative ResultsTomas LinkeviciusCompletedNot Applicable
NCT07574710Completed
Not Applicable
Effects of Implant Placement Depth (4 mm Versus 6 mm) on Crestal Bone Stability...Tomas Linkevicius
NCT07576725
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialFred Hutchinson Cancer CenterNot Yet RecruitingPhase 2
NCT07576725Not Yet Recruiting
Phase 2
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metas...Fred Hutchinson Cancer Ce...
NCT07576049
COLORECTAL CANCER: SINGLE CENTER EXPERIENCEUniversity of Roma La SapienzaEnrolling By Invitation
NCT07576049Enrolling By Invitation
—
COLORECTAL CANCER: SINGLE CENTER EXPERIENCEUniversity of Roma La Sap...
NCT07576998
PHIL™ Middle Meningeal Artery Embolization for First-Line Treatment of Chronic Subdural Hematoma IDE TrialMicrovention-Terumo, Inc.Not Yet RecruitingNot Applicable
NCT07576998Not Yet Recruiting
Not Applicable
PHIL™ Middle Meningeal Artery Embolization for First-Line Treatment of Chronic S...Microvention-Terumo, Inc.
NCT07575113
Comparison of Otago and Beat it Program on Balance, Gait and QOL in Diabetic NeuropathyRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07575113Not Yet Recruiting
Not Applicable
Comparison of Otago and Beat it Program on Balance, Gait and QOL in Diabetic Neu...Riphah International Univ...
NCT07575841
Pulmonary Rehabilitation Frequency in COPD PatientsHospital Universitario Fundación AlcorcónNot Yet RecruitingNot Applicable
NCT07575841Not Yet Recruiting
Not Applicable
Pulmonary Rehabilitation Frequency in COPD PatientsHospital Universitario Fu...
NCT07576972
Human Milk Concentrating Device to Optimize Mother's Own MilkBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576972Not Yet Recruiting
Not Applicable
Human Milk Concentrating Device to Optimize Mother's Own MilkBeth Israel Deaconess Med...
NCT07575581
Psychometric Evaluation of the EVARUCI Scale in Turkish Intensive Care UnitsIstanbul UniversityCompleted
NCT07575581Completed
—
Psychometric Evaluation of the EVARUCI Scale in Turkish Intensive Care UnitsIstanbul University
NCT07576959
Effect of Bismuth Add-on to Dual Therapy for Helicobacter Pylori EradicationNational Taiwan University HospitalRecruitingPhase 3
NCT07576959Recruiting
Phase 3
Effect of Bismuth Add-on to Dual Therapy for Helicobacter Pylori EradicationNational Taiwan Universit...
NCT07576257
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure -Extension (OPRA-HF Extension)Sahlgrenska University HospitalNot Yet RecruitingPhase 2
NCT07576257Not Yet Recruiting
Phase 2
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili...Sahlgrenska University Ho...
NCT07575373
Evaluating the Feasibility of an Interdisciplinary Primary Care-based Intervention to Improve Transitions to Follow-Up Care for Hospitalized Patients With Substance Use DisordersMichael InczeNot Yet RecruitingNot Applicable
NCT07575373Not Yet Recruiting
Not Applicable
Evaluating the Feasibility of an Interdisciplinary Primary Care-based Interventi...Michael Incze
NCT07576907
Ayre's Sensory-Motor Integration Exercises and Sensory Modulation And Motor Skills In Children With ASDRiphah International UniversityRecruitingNot Applicable
NCT07576907Recruiting
Not Applicable
Ayre's Sensory-Motor Integration Exercises and Sensory Modulation And Motor Skil...Riphah International Univ...
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07574658
Brief Cognitive Behavioral Therapy for Suicide Prevention in a Brazilian Sample: a Study Protocol of a Randomized Clinical TrialUniversity of Sao PauloNot Yet RecruitingPhase 3
NCT07574658Not Yet Recruiting
Phase 3
Brief Cognitive Behavioral Therapy for Suicide Prevention in a Brazilian Sample:...University of Sao Paulo
NCT07575893
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering Cancer CenterNot Yet RecruitingPhase 1
NCT07575893Not Yet Recruiting
Phase 1
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering...
NCT07575568
Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal LumenAustralian Healthcare SolutionsNot Yet RecruitingNot Applicable
NCT07575568Not Yet Recruiting
Not Applicable
Revascularization With Modification Using Definitive IVL and Serration Remodelin...Australian Healthcare Sol...
Result Breakdown
Not yet recruiting13 (65%)
Completed3 (15%)
Recruiting3 (15%)
Enrolling by invitation1 (5%)
not_applicable10 (50%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 32 (10%)
Phase 11 (5%)